Literature DB >> 6253527

Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro.

R D Diamond, R A Clark, C C Haudenschild.   

Abstract

In previous studies, we noted that Candida hyphae and pseudohyphae could be damaged and probably killed by neutrophils, primarily by oxygen-dependent nonphagocytic mechanisms. In extending these studies, amount of damage to hyphae again was measured by inhibition of [(14)C]cytosine uptake. Neutrophils from only one of four patients with chronic granulomatous disease damaged hyphae at all, and neutrophils from this single patient damaged hyphae far less efficiently than simultaneously tested neutrophils from normal control subjects. Neutrophils from neither of two subjects with hereditary myeloperoxidase deficiency damaged the hyphae. This confirmed the importance of oxidative mechanisms in general and myeloperoxidase-mediated systems in particular in damaging Candida hyphae. Several potentially fungicidal oxidative intermediates are produced by metabolic pathways of normal neutrophils, but their relative toxicity for Candida hyphae was previously unknown. To help determine this, cell-free in vitro systems were used to generate these potentially microbicidal products. Myeloperoxidase with hydrogen peroxide, iodide, and chloride resulted in 91.2% damage to hyphal inocula in 11 experiments. There was less damage when either chloride or iodide was omitted, and no damage when myeloperoxidase was omitted or inactivated by heating. Azide, cyanide, and catalase (but not heated catalase) inhibited the damage. Systems for generation of hydrogen peroxide could replace reagent hydrogen peroxide in the myeloperoxidase system. These included glucose oxidase, in the presence of glucose, and xanthine oxidase, in the presence of either hypoxanthine or acetaldehyde. In the presence of myeloperoxidase and a halide, the toxicity of the xanthine oxidase system was not inhibited by superoxide dismutase and, under some conditions, was marginally increased by this enzyme. This suggested that superoxide radical did not damage hyphae directly but served primarily as an intermediate in the production of hydrogen peroxide. The possible damage to hyphae by singlet oxygen was examined using photoactivation of rose bengal. This dye damaged hyphae in the presence of light and oxygen. The effect was almost completely inhibited by putative quenchers of singlet oxygen: histidine, tryptophan, and 1,4-diazobicyclo[2.2.2]octane. These agents also inhibited damage to hyphae by myeloperoxidase, halide, and either hydrogen peroxide or a peroxide source (xanthine oxidase plus acetaldehyde). Myeloperoxidase-mediated damage to hyphae was also inhibited by dimethyl sulfoxide, an antioxidant and scavenger of the hydroxyl radical. These data support the involvement of oxidative mechanisms and the myeloperoxidase-H(2)O(2)-halide system, in particular in damaging hyphae in vitro and perhaps in vivo as well.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253527      PMCID: PMC371525          DOI: 10.1172/JCI109958

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Myeloperoxidase and singlet oxygen: a reappraisal.

Authors:  J E Harrison; B D Watson; J Schultz
Journal:  FEBS Lett       Date:  1978-08-15       Impact factor: 4.124

2.  Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system.

Authors:  H Rosen; S J Klebanoff
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

3.  Ambiguity associated with use of singlet oxygen trapping agents in myeloperoxidase-catalyzed oxidations.

Authors:  A M Held; J K Hurst
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

4.  Singlet oxygen: a major reactive species in the furocoumarin photosensitized inactivation of E. coli ribosomes.

Authors:  H Singh; J A Vadasz
Journal:  Photochem Photobiol       Date:  1978 Oct-Nov       Impact factor: 3.421

5.  The production of superoxide radical during the decomposition of potassium peroxochromate(V).

Authors:  E K Hodgson; I Fridovich
Journal:  Biochemistry       Date:  1974-08-27       Impact factor: 3.162

6.  Antifungal effects of peroxidase systems.

Authors:  R I Lehrer
Journal:  J Bacteriol       Date:  1969-08       Impact factor: 3.490

7.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

8.  Myeloperoxidase--H2O2--halide system: cytotoxic effect on human blood leukocytes.

Authors:  R A Clark; S J Klebanoff
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

9.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide.

Authors:  J E Repine; J W Eaton; M W Anders; J R Hoidal; R B Fox
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

View more
  41 in total

1.  Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase.

Authors:  O I Aruoma; B Halliwell
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

2.  Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli.

Authors:  H Rosen; B R Michel
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.

Authors:  Mahmoud A Ghannoum; Pranab K Mukherjee; Richard J Jurevic; Mauricio Retuerto; Robert E Brown; Masoumeh Sikaroodi; Jennifer Webster-Cyriaque; Patrick M Gillevet
Journal:  OMICS       Date:  2011-07-13

4.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.

Authors:  C J Morrison; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.

Authors:  Alaka Mullick; Miria Elias; Penelope Harakidas; Anne Marcil; Malcolm Whiteway; Bing Ge; Thomas J Hudson; Antoine W Caron; Lucie Bourget; Serge Picard; Orce Jovcevski; Bernard Massie; David Y Thomas
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Effect of dialysate fluids on phagocytosis and killing by normal neutrophils.

Authors:  D M Harvey; K J Sheppard; A G Morgan; J Fletcher
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Authors:  E Blasi; L Pitzurra; M Puliti; L Lanfrancone; F Bistoni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system.

Authors:  S M Levitz; R D Diamond
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.